EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

Clinical trial NCT05284747 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05284747
Sponsor: Amgen
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Cardiovascular Disease Myocardial Infarction Stroke Coronary Revascularization

Start date: 2022-10-26
Primary completion: 2027-05-29
Enrollment: 6019

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.